Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia
Status:
Completed
Trial end date:
2020-12-10
Target enrollment:
Participant gender:
Summary
The aim of the present study is comparing the effectiveness of different treatment regimens
for investigating the therapeutic potential for each one in management of Vaso-occlusive pain
in pediatric sickle cell disease. In addition, investigators apply the Cost-effectiveness
analysis (CEA) as a form of economic analysis that compares the relative costs and outcomes
(effects) for different treatment regimens on vaso-occlusive painful crisis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Beni-Suef University
Collaborators:
Benisuef university hospital College of Pharmacy,Department of Pharmacy Practice,University of Arizona Department of clinical pharmacy, faculty of pharmacy, Beni-suef univeristy Maternity and Children Hospital, Makkah University of Arizona
Treatments:
Analgesics Folic Acid Hydroxymethylglutaryl-CoA Reductase Inhibitors Hydroxyurea Morphine Simvastatin Vitamin B Complex Vitamin D Zinc Zinc Sulfate